UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 120

Sortiert nach

Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients

BMC genomics, 2009-08, Vol.10 (1), p.405-405, Article 405

2009

Volltextzugriff (PDF)

Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis

Nature genetics, 2008-01, Vol.40 (1), p.29-31

2008

Volltextzugriff (PDF)

Another milestone in childhood spinal muscular atrophy

Lancet neurology, 2017-07, Vol.16 (7), p.491-492

Wokke, John H

2017

Volltextzugriff (PDF)

Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations

Journal of neurology, 2011-02, Vol.258 (2), p.218-222

2011

Volltextzugriff (PDF)

Clinical features of late-onset Pompe disease: A prospective cohort study

Muscle & nerve, 2008-10, Vol.38 (4), p.1236-1245

2008

Volltextzugriff (PDF)

Pre‐ and postsynaptic neuromuscular junction abnormalities in musk myasthenia

Muscle & nerve, 2010-08, Vol.42 (2), p.283-288

2010

Volltextzugriff (PDF)

Relative contribution of mutations in genes for autosomal dominant distal hereditary motor neuropathies: a genotype–phenotype correlation study

Brain (London, England : 1878), 2008-05, Vol.131 (5), p.1217-1227

2008

Volltextzugriff (PDF)

Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis

Annals of neurology, 2009-08, Vol.66 (2), p.227-234

2009

Volltextzugriff (PDF)

Genome-wide association study identifies 19p13.3 ( UNC13A ) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis

Nature genetics, 2009-10, Vol.41 (10), p.1083-1087

2009

Volltextzugriff (PDF)

Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease

Cochrane database of systematic reviews, 2012-11, Vol.11, p.CD002064

2012

Volltextzugriff (PDF)

Cold paresis in multifocal motor neuropathy

Journal of neurology, 2011-02, Vol.258 (2), p.212-217

2011

Volltextzugriff (PDF)

A randomized sequential trial of creatine in amyotrophic lateral sclerosis

Annals of neurology, 2003-04, Vol.53 (4), p.437-445

2003

Volltextzugriff (PDF)

Drug treatment for spinal muscular atrophy types II and III

Cochrane database of systematic reviews, 2012-04 (4), p.CD006282

2012

Volltextzugriff (PDF)

Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study

Orphanet journal of rare diseases, 2012-11, Vol.7 (1), p.88-88

2012

Volltextzugriff (PDF)

Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acid

Journal of neurology, neurosurgery and psychiatry, 2011-08, Vol.82 (8), p.850-852

2011

Volltextzugriff (PDF)

Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis

Brain (London, England : 1878), 2005-10, Vol.128 (10), p.2327-2337

2005

Volltextzugriff (PDF)

Euthanasia and Physician-Assisted Suicide among Patients with Amyotrophic Lateral Sclerosis in the Netherlands

The New England journal of medicine, 2002-05, Vol.346 (21), p.1638-1644

2002

Volltextzugriff (PDF)

Entrapment in anti myelin-associated glycoprotein neuropathy

Journal of neurology, 2009-04, Vol.256 (4), p.620-624

2009

Volltextzugriff (PDF)

Multifocal motor neuropathy

Lancet neurology, 2005-05, Vol.4 (5), p.309-319

2005

Volltextzugriff (PDF)

Copy-number variation in sporadic amyotrophic lateral sclerosis: a genome-wide screen

Lancet neurology, 2008-04, Vol.7 (4), p.319-326

2008

Volltextzugriff (PDF)

Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis

Proceedings of the National Academy of Sciences - PNAS, 2009-06, Vol.106 (22), p.9004-9009

2009

Volltextzugriff (PDF)

Spastin mutations in sporadic adult-onset upper motor neuron syndromes

Annals of neurology, 2005-12, Vol.58 (6), p.865-869

2005

Volltextzugriff (PDF)

Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study

Orphanet journal of rare diseases, 2012-09, Vol.7 (1), p.73-73, Article 73

2012

Volltextzugriff (PDF)

Drug treatment for spinal muscular atrophy type I

Cochrane database of systematic reviews, 2009-01 (1), p.CD006281

2009

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(116)
Reviews
(3)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(93)
Science & Technology
(93)
Life Sciences & Biomedicine
(92)
Neurosciences & Neurology
(69)
Clinical Neurology
(64)
Female
(55)
Male
(54)
Neurology
(50)
Biological And Medical Sciences
(47)
Medical Sciences
(46)
Middle Aged
(46)
Adult
(45)
Neurosciences
(37)
Aged
(29)
Amyotrophic Lateral Sclerosis
(19)
Adolescent
(16)
Disease Progression
(15)
Nervous System
(14)
Mutation
(13)
Amyotrophic Lateral Sclerosis - Genetics
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients

Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis

Another milestone in childhood spinal muscular atrophy

Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations

Clinical features of late-onset Pompe disease: A prospective cohort study

Pre‐ and postsynaptic neuromuscular junction abnormalities in musk myasthenia

Relative contribution of mutations in genes for autosomal dominant distal hereditary motor neuropathies: a genotype–phenotype correlation study

Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis

Genome-wide association study identifies 19p13.3 ( UNC13A ) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis

Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease

Cold paresis in multifocal motor neuropathy

A randomized sequential trial of creatine in amyotrophic lateral sclerosis

Drug treatment for spinal muscular atrophy types II and III

Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study

Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acid

Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis

Euthanasia and Physician-Assisted Suicide among Patients with Amyotrophic Lateral Sclerosis in the Netherlands

Entrapment in anti myelin-associated glycoprotein neuropathy

Multifocal motor neuropathy

ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study

Copy-number variation in sporadic amyotrophic lateral sclerosis: a genome-wide screen

Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis

Spastin mutations in sporadic adult-onset upper motor neuron syndromes

Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study

Drug treatment for spinal muscular atrophy type I

Suchergebnisse filtern